Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Events
  • Tools
    • Members
    • Groups
    • Add/Edit Event
    • My Bookings
      • Manage Bookings
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
  • COVID-19

Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), headquartered in West Chester, PA, is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. For more information, visit www.verrica.com.

Verrica Pharmaceuticals Inc
Public Companies

Verrica Pharmaceuticals Announces Participation in the 20th Annual Needham Virtual Healthcare Conference

April 7, 2021April 7, 2021 - by MyChesCo

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) this week announced that Ted White, Verrica President and CEO, will present a business overview at the 20th Annual Needham Virtual …

Read More

Verrica Pharmaceuticals Inc
Executives

Verrica Announces Chief Medical Officer’s Membership in the American Dermatological Association

March 31, 2021March 31, 2021 - by MyChesCo

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that Gary Goldenberg, M.D., Verrica’s Chief Medical Officer, …

Read More
Verrica Pharmaceuticals Inc
Equities

Verrica Announces Proposed Public Offering of Common Stock

March 24, 2021March 23, 2021 - by MyChesCo

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that it intends to offer and sell, subject …

Read More

Verrica Pharmaceuticals Inc
Strategic Combinations

Verrica Pharmaceuticals Announces Exclusive Licensing Agreement With Torii Pharmaceutical Co.

March 18, 2021March 18, 2021 - by MyChesCo

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced today that it has entered into a License …

Read More
Verrica Pharmaceuticals Inc
Finance

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results

March 6, 2021March 6, 2021 - by MyChesCo

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) recently announced financial results for the fourth quarter ended December 31, 2020.

Read More

Verrica Pharmaceuticals Inc
Public Companies

Verrica Pharmaceuticals to Participate in H.C. Wainwright Annual Global Life Sciences Conference

March 6, 2021March 4, 2021 - by MyChesCo

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that Ted White, Verrica President and CEO, will …

Read More
Verrica Pharmaceuticals Inc
Public Companies

Verrica Pharmaceuticals Announces Participation in the Cowen 41st Annual Health Care Conference

February 25, 2021February 25, 2021 - by MyChesCo

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that Ted White, Verrica President and CEO, will …

Read More

Verrica Pharmaceuticals Inc
Products and Services / Research

Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application

February 20, 2021February 20, 2021 - by MyChesCo

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that its resubmitted New Drug Application (NDA) for …

Read More
Verrica Pharmaceuticals Inc
Products and Services / Research

Verrica Pharmaceuticals Presents Clinical Studies Data at 2021 Winter Clinical Dermatology Conference

January 20, 2021January 20, 2021 - by MyChesCo

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced the presentation of positive data from post-hoc pooled …

Read More
Verrica Pharmaceuticals Inc
Products and Services / Research

Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102

December 25, 2020December 25, 2020 - by MyChesCo

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it has resubmitted the New Drug …

Read More

Posts navigation

1 2 3 Next

Most Read

  • Police Ask for Help Identifying Shoplifting Suspect
  • IRS Suspends Requirement to Repay Excess Advance Payments of the 2020 Premium Tax Credit
  • 7 Amazing Drive-In Movie Theaters Near Chester County
  • Exton Little League Celebrates Opening Day on New Fields
  • Stimulus Payments to Non-filer Social Security, Federal Beneficiaries Will Be Disbursed this Week
  • Secretary of Agriculture Recognizes Benefits of Kennel Inspections for Quality Dog Breeders, Consumers

Subscribe for Updates

Chester County Events

  • Invasive plant removal, Goose Creek
    • 04/17/2021
  • Chance McCoy (of Old Crow Medicine Show)
    • 04/22/2021
      Wayne
  • Cinco De Mayo Bar Crawl West Chester
    • 05/01/2021
      West Chester
  • Pennhurst
    • 05/01/2021 - 05/02/2021
      Spring City
  • Phoenixville Beer & Wine Festival 2021
    • 05/08/2021
      Phoenixville
  • all events

Follow Us

  • Facebook
  • Twitter
  • LinkedIn

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy

Recommended Reading

  • FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer
  • Secretary of Agriculture Announces $1 Million Farm Vitality Grant Program
  • FTC Seeks Public Comment on Dark Patterns Topics
  • Commonwealth Will Transition to New Unemployment Compensation System in June
  • IRS Suspends Requirement to Repay Excess Advance Payments of the 2020 Premium Tax Credit
Copyright © 2021 MyChesCo.